The Gila monster gave the weight-loss revolution its bite
It’s currently estimated that over one-half of the adult US population is either overweight or obese. Being overweight means having a Body Mass Index (BMI) between 25 and 30. Obese means a BMI higher than 30. This statistic shouldn’t be taken to indicate neglect by the healthcare, research, or pharmaceutical industry. In reality, enormous attention […]
Treating Obstructive Sleep Apnea with Tirzepatide
Interrupted breathing during sleep, technically known as Obstructive Sleep Apnea (OSA), is a fairly common problem that has, until now, been difficult to address with pharmaceutical treatment. OSA has one quite special characteristic, in that people living with the condition often don’t know that they have it because it occurs only when they are sound […]
Do GLP-1 drugs stop working? Myths, facts and strategies
If it hadn’t been for the crisis that hit the world when COVID-19 broke out in 2020, I believe that the revelations about the new weight-loss drugs would have reached the top of the list of the most talked-about health issues in the current decade. It has garnered the highest level of public interest and […]
Buy Compounded Tirzepatide for Less at IsraelPharm
A crisis struck in 2023 and persisted well into the first few months of 2024. Patients relying on vital medications for diabetes faced a frightening reality: pharmacies, including ours, had to turn away their orders due to shortages. Earlier this year, we published an article detailing the causes of the shortages, titled “Why is it […]
What You Need to Know About Wegovy for Weight Loss
Wegovy, the latest form of semaglutide GLP-1 weight-loss medication, has received a flood of media and public attention thanks to the effectiveness of weight management with Wegovy, which promotes rapid and sustainable weight and waistline reductions. Since we added it to our inventory, we have received a lot of positive feedback from our customers, many of which […]
Medicare now approves weight-loss drugs for people with heart problems
There has been much attention in the media to an announcement from Medicare in mid-March 2024. In essence, it said that it has now agreed to start paying for one of the leading weight-loss drugs for people with heart problems when it is prescribed to treat overweight or obese patients if they are at risk […]
Why it’s so hard to get your weight-loss drugs
On February 2nd, 2024, the venerable New York Times published an article titled “Six Reasons Why It’s So Hard to Get Your Weight-Loss Drugs”. There were few surprises for us in what the NYT wrote because we have been hearing many of the same complaints from new customers who have been struggling to fill their […]
Changes in insurance coverage for Ozempic
There’s been a rapid revolution in how U.S. insurers cover (or don’t cover) the cost of the newer type 2 diabetes medications like Ozempic, Wegovy, and Mounjaro. In this short article, we offer a general overview of the highly volatile situation concerning insurance coverage for these medicines. We aren’t trying to predict what could be […]
Combating GLP-1 hair loss with Phyllotex
Losing weight can truly feel like a victory. But along with the celebratory feeling of weight loss many people experience while using new GPL1 weight loss drugs like Ozempic – there can be another unwelcome side effect: loss of hair health. While the exact connection is still being investigated, many are looking for immediate solutions […]
What’s the difference between Ozempic and Mounjaro?
Ozempic / Wegovy and Mounjaro / Zepbound (and their base components semaglutide and tirzepatide) are currently the “hottest” medications on the market. You don’t have to be a doctor or pharmacist to get to this conclusion; the stock market tells the story. Sales of Ozempic / Wegovy (based on semaglutide) from Novo Nordisk and Mounjaro / […]